RUNX1 and myeloid neoplasm: Finally, the presence of spliceosomal mutations in myeloid malignancies has been demonstrated to impact the alternative splicing of the terminal exon of AML1 [32], and splicing changes related to exon 6 of AML1 differentially regulate hematopoiesis in mice [33].